Outcomes for COPD pharmacological trials: from lung function to biomarkers

Symposium
Chairs: W. MacNee (Edinburgh, United Kingdom), F. Martinez (Ann Arbor, United States of America)
Aims: Presentation and discussion of the document of the ATS/ERTS Task Force on outcomes in COPD. Target audience: Physicians, clinical and basic scientists, fellows, nurses and other allied health care professionals.

Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD K. F. Rabe (Leiden, The Netherlands)
Recommendations of the ATS/ERS Task Force for the definition of outcomes for COPD pharmacological trials M. Cazzola (Naples, Italy)